“…In patients with OSA, this leads to nocturnal apneas and hypopneas, intermittent hypoxia, reoxygenation and hyper-/hypocapnia events, along with sleep fragmentation, and changes in cerebral blood flow (Baril et al, 2015, Shiota et al, 2014, Yadav et al, 2013). The prevalence of OSA is noticeable in general population and around 50% in patients with cardiovascular or metabolic disorders (Khazaie et al, 2013, Khazaie et al, 2011, Lévy et al, 2015, Lurie, 2011).…”